ImmunityBio, Inc 10-K for FY2024
ImmunityBio, Inc. (IBRX)
10-K
2025-03-03
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
ImmunityBio, Inc filed this 10-K on March 3, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $14.75M
- up 2270.6% from $622K a year earlier
- Net loss
- $413.56M
- compared with a net loss of $583.2M a year earlier
- Diluted EPS
- -$0.62
- compared with -$1.15 a year earlier